EUVIMEDEUVIMED entdecken
Crossref

Burden of Type 2 Diabetes from the Healthcare Payer Perspective in Slovenia / Breme Sladkorne Bolezni Tipa 2 S Stališča Plačnika Zdravstvenega Varstva V Sloveniji

Tomaž Nerat, Mitja Kos

Slovenian Journal of Public Health · 2013

DOI: 10.2478/sjph-2013-0018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Slovenian Journal of Public Health, 2013. Verfasst von Tomaž Nerat und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetes prevalence and costs are rising on aglobal scale. Therefore, it is necessary to periodically conduct cost studies for assessing the healthcare burden impact. In Slovenia, the last type 2 diabetes cost assessment was conducted in 2006, not including all diabetes complication costs. The aim of this study was to revise, update and compare to previously published datadirect healthcare costs of type 2 diabetes in Slovenia with additional complications costs consideration.

Methods

The study was performed from the healthcare payer perspective using the bottom-up approach, was prevalence based and estimated direct medical costs.

Results

We estimated total yearly direct medical costs of type 2 diabetes in Slovenia to 99,120,419 euro with annual per capita costs of 834.70 euro. The highest cost shares were attributed to cardiovascular complication costs (21,683,919 euro), diabetes co-medication (20,977,269 euro) and diabetes treatment medication (18,505,015 euro). Highest yearly costs per complication (all cases, all occurrences) were estimated for dialysis I and III (9,162,635 euro), stroke first year costs (4,951,306 euro) and congestive heart failure first year costs (4,879,533 euro). Yearly per one patient, the complication costs were highest for kidney transplantation, followed by dialysis I and III (78,621.25 euro and 36,797.73 euro)

Conclusions

In comparison to the costs published in the literature before, our estimated total yearly direct medical costs were comparable, although annual per capita costs were assessed lower than elsewhere. Further, regarding the complication costs estimations, our assessed expenses were comparable to those published in other countries.

Zitieren

APA

Nerat, T., & Kos, M. (2013). Burden of Type 2 Diabetes from the Healthcare Payer Perspective in Slovenia / Breme Sladkorne Bolezni Tipa 2 S Stališča Plačnika Zdravstvenega Varstva V Sloveniji. Slovenian Journal of Public Health. https://doi.org/10.2478/sjph-2013-0018

Vancouver

Nerat T, Kos M. Burden of Type 2 Diabetes from the Healthcare Payer Perspective in Slovenia / Breme Sladkorne Bolezni Tipa 2 S Stališča Plačnika Zdravstvenega Varstva V Sloveniji. Slovenian Journal of Public Health. 2013. doi:10.2478/sjph-2013-0018

BibTeX
@article{Nerat2013,
  author = {Nerat, Tomaž and Kos, Mitja},
  title = {Burden of Type 2 Diabetes from the Healthcare Payer Perspective in Slovenia / Breme Sladkorne Bolezni Tipa 2 S Stališča Plačnika Zdravstvenega Varstva V Sloveniji},
  journal = {Slovenian Journal of Public Health},
  year = {2013},
  doi = {10.2478/sjph-2013-0018}
}
Kostenlos starten →